$9.16
Price
$1.6B
Market Cap
—
P/E Ratio
-5.6
Forward P/E
$-1.72
EPS (TTM)
—
Dividend Yield
$596M
Cash
$49M
Total Debt
173M
Shares Out
$1.77
$9.54
52-Week Range
Institutional Ownership of RELAY THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for RELAY THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q4 | |||||
| SELL | EXIT | — | — | $19.02 | |
| 2022-Q3 | |||||
| BUY | NEW | 100.0K | $2M | $21.64 | |
Insider Trading for RELAY THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $1.5M
0
Buys
6
Sells
-1.5M
Net
1
Grants
Largest
$435K
Patel
$338K
Patel
$225K
Bergstrom
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 06, 2026 | Sanjiv Patel | President and CEO | SELL | 43.2K | $7.82 | $338K |
| Dec 31, 2025 | Sanjiv Patel | President and CEO | GRANT | 994 | $2.99 | $3K |
| Nov 03, 2025 | Sanjiv Patel | President and CEO | SELL | 62.1K | $7.00 | $435K |
| Oct 29, 2025 | Peter Rahmer | Chief Corporate Development Officer; Exhibit 24 - Power of Attorney | SELL | 21.4K | $7.50 | $160K |
| Oct 28, 2025 | Donald A Bergstrom | President, R&D | SELL | 30.9K | $7.29 | $225K |
| Oct 28, 2025 | Peter Rahmer | Chief Corporate Development Officer; Exhibit 24 - Power of Attorney | SELL | 19.1K | $7.29 | $139K |
| Oct 28, 2025 | Thomas Catinazzo | Chief Financial Officer | SELL | 21.7K | $7.29 | $158K |